Price T Rowe Associates Inc Heron Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 37,495 shares of HRTX stock, worth $41,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,495

Previous 37,495 -0.0%

Holding current value

$41,244

Previous $132,000 43.18%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $17,569 - $29,231	7,573 Added 25.31%	37,495 $132,000
Q1 2024 May 15, 2024	BUY	$1.71 - $3.06 $6,824 - $12,212	3,991 Added 15.39%	29,922 $83,000
Q4 2023 Feb 14, 2024	BUY	$0.54 - $1.82 $2,768 - $9,331	5,127 Added 24.64%	25,931 $45,000
Q3 2023 Nov 14, 2023	SELL	$0.97 - $1.8 $34,726 - $64,440	-35,800 Reduced 63.25%	20,804 $22,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.88 $2,272 - $5,895	2,047 Added 3.75%	56,604 $66,000
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $9,543 - $20,540	6,320 Added 13.1%	54,557 $83,000
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $4,765 - $9,891	2,118 Added 4.59%	48,237 $121,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $38,173 - $77,064	14,351 Added 45.17%	46,119 $195,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $3,357 - $9,183	-1,460 Reduced 4.39%	31,768 $89,000
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $14,968 - $32,136	3,233 Added 10.78%	33,228 $190,000
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $195,390 - $294,840	-23,400 Reduced 43.82%	29,995 $274,000
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $28,364 - $42,000	2,800 Added 5.53%	53,395 $571,000
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $90,581 - $126,144	-6,826 Reduced 11.89%	50,595 $785,000
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $189,485 - $270,955	-13,077 Reduced 18.55%	57,421 $931,000
Q4 2020 Feb 16, 2021	BUY	$14.61 - $22.14 $1.03 Million - $1.56 Million	70,498 New	70,498 $1.49 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $131M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Heron Therapeutics, Inc. Transaction History